Nek2 as an effective target for inhibition of tumorigenic growth and peritoneal dissemination of cholangiocarcinoma

Cancer Research

Volumn 67, Issue 20, 2007, Pages 9637-9642

  Kokuryo, Toshio ^a   Senga, Takeshi ^a   Yokoyama, Yukihiro ^a   Nagino, Masato ^a   Nimura, Yuji ^a   Hamaguchi, Michinari ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN NEK2; PROTEIN SERINE THREONINE KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT CARCINOMA; CANCER GENE THERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER SIZE; CONTROLLED STUDY; DISEASE ASSOCIATION; MALE; MOUSE; NONHUMAN; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL DEATH; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CHOLANGIOCARCINOMA; DNA, COMPLEMENTARY; GENE EXPRESSION; HUMANS; LIVER; MALE; MICE; MICE, NUDE; PERITONEAL NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL INTERFERING;

EID: 35448935555     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-1489     Document Type: Article

References (18)

1. Nimura Y, Kamiya J, Nagino M, et al. Aggressive surgical treatment of hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 1998;5:52-61.
2. Capdeville R, Buchdunger E, Zimmermann J, Matter A. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov 2002;1:493-502.
3. Fry AM, Meraldi P, Nigg EA. A centrosomal function for the human Nek2 protein kinase, a member of the NIMA family of cell cycle regulators. EMBO J 1998;17:470-481.
4. Fry AM. The Nek2 protein kinase: a novel regulator of centrosome structure. Oncogene 2002;21:6184-94.
5. Nagino M, Kamiya J, Arai T, Nishio H, Ebata T, Nimura Y. One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome. Surgery 2005;137:148-55.
6. Kokuryo T, Yamamoto T, Oda K, et al. Profiling of gene expression associated with hepatolithiasis by complementary DNA expression array. Int J Oncol 2003;22:175-9.
7. Fletcher L, Cerniglia GJ, Nigg EA, Yend TJ, Muschel RJ. Inhibition of centrosome separation after DNA damage: a role for Nek2. Radiat Res 2004;162:128-35.
8. Hayward DG, Clarke RB, Faragher AJ, Pillai MR, Hagan IM, Fry AM. The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer. Cancer Res 2004;64:7370-6.
9. Prigent C, Glover DM, Giet R. Drosophila Nek2 protein kinase knockdown leads to centrosome maturation defects while overexpression causes centrosome fragmentation and cytokinesis failure. Exp Cell Res 2005;303:1-13.
10. Hayward DG, Fry AM. Nek2 kinase in chromosome instability and cancer. Cancer Lett 2006;237:155-66.
11. Machida K, Matsuda S, Yamaki K, et al. v-Src suppresses SHPS-1 expression via the Ras-MAP kinase pathway to promote the oncogenic growth of cells. Oncogene 2000;19:1710-8.
12. Hamaguchi M, Matsuyoshi N, Ohnishi Y, Gotoh B, Takeichi M, Nagai Y. p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system. EMBO J 1993;12:307-14.
13. Mon NN, Ito S, Senga T, Hamaguchi M. FAK signaling in neoplastic disorders: a linkage between inflammation and cancer. Ann N Y Acad Sci 2006;1086:199-212.
14. Fardilha M, Wu W, Sa R, et al. Alternatively spliced protein variants as potential therapeutic targets for male infertility and contraception. Ann N Y Acad Sci 2004;1030:468-78.
15. Weber SM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg 2002;235:392-9.
16. Weinstein IB. Addiction to oncogenes - the Achilles heal of cancer. Science 2002;297:63-4.
17. Takei Y, Kadomatsu K, Yuzawa Y, Matsuo S, Muramatsu T. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res 2004;64:3365-70.
18. Heidel JD, Hu S, Liu XF, Triche TJ, Davis ME. Lack of interferon response in animals to naked siRNAs. Nat Biotechnol 2004;22:1579-82.